Grassley slams secrecy in healthcare pricing
A Republican senator has criticised the lack of transparency on drug pricing in the US, arguing that the mystery behind price negotiations make it difficult for Congress and consumers to follow the money.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10